Vext Science, Inc.
VEXTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $36 | $35 | $35 | $37 |
| % Growth | 3.4% | -1.7% | -4.9% | – |
| Cost of Goods Sold | $27 | $23 | $12 | $19 |
| Gross Profit | $9 | $12 | $23 | $19 |
| % Margin | 24.9% | 34.6% | 65.2% | 50.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $11 | $8 | $10 | $5 |
| SG&A Expenses | $11 | $14 | $10 | $6 |
| Sales & Mktg Exp. | $0 | $6 | $0 | $0 |
| Other Operating Expenses | $9 | $0 | $4 | $4 |
| Operating Expenses | $20 | $14 | $14 | $9 |
| Operating Income | -$11 | -$2 | $9 | $9 |
| % Margin | -31.1% | -5.2% | 25.2% | 25.5% |
| Other Income/Exp. Net | -$10 | $5 | -$7 | -$3 |
| Pre-Tax Income | -$21 | $3 | $7 | $7 |
| Tax Expense | $1 | -$1 | -$4 | $2 |
| Net Income | -$22 | $4 | $11 | $5 |
| % Margin | -62.3% | 12.6% | 30.8% | 13.4% |
| EPS | -0.093 | 0.027 | 0.076 | 0.036 |
| % Growth | -448.7% | -64.6% | 109.1% | – |
| EPS Diluted | -0.093 | 0.027 | 0.075 | 0.034 |
| Weighted Avg Shares Out | 241 | 164 | 139 | 137 |
| Weighted Avg Shares Out Dil | 241 | 165 | 140 | 146 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $4 | $4 | $2 | $2 |
| Depreciation & Amortization | $15 | $10 | $6 | $3 |
| EBITDA | -$2 | $17 | $15 | $13 |
| % Margin | -5.6% | 49.9% | 42.4% | 34.4% |